[4] |
Radford MG Jr, Donadio JV Jr, Bergstralh EJ, et al. Predicting renal outcome in IgA nephropathy [J]. J Am Soc Nephrol, 1997, 8(2): 199-207.
|
[5] |
Espinosa M, Ortega R, Sánchez M, et al. Association of C4d deposition with clinical outcomes in IgA nephropathy [J]. Clin J Am Soc Nephrol, 2014, 9(5): 897-904
|
[6] |
Daha MR, van Kooten C. Role of complement in IgA nephropathy [J]. J Nephrol, 2016, 29(1): 1-4.
|
[7] |
Janssen BJ, Christodoulidou A, McCarthy A, et al. Structure of C3b reveals conformational changes that underlie complement activity [J]. Nature, 2006, 444(7116): 213-216.
|
[8] |
Yeo SC, Cheung CK, Barratt J. New insights into the pathogenesis of IgA nephropathy [J]. Pediatr Nephrol, 2018, 33(5): 763-777.
|
[9] |
Floege J, Daha MR. IgA nephropathy: new insights into the role of complement [J]. Kidney Int, 2018, 94(1): 16-18.
|
[10] |
Onda K, Ohsawa I, Ohi H, et al. Excretion of complement proteins and its activation marker C5b-9 in IgA nephropathy in relation to renal function [J]. BMC Nephrology, 2011, 12: 64.
|
[11] |
Onda K, Ohi H, Tamano M, et al. Hypercomplementemia in adult patients with IgA nephropathy [J]. J Clin Lab Anal, 2007, 21(2): 77-84.
|
[12] |
Hiemstra PS, Gorter A, Stuurman ME, et al. Activation of the alternative pathway of complement by human serum IgA [J]. Eur J Immunol, 1987, 17(3): 321-326.
|
[13] |
Maillard N, Wyatt RJ, Julian BA, et al. Current understanding of the role of complement in IgA nephropathy [J]. J Am Soc Nephrol, 2015, 26(7): 1503-1512.
|
[14] |
朱厉,张宏. IgA肾病的精准医学研究进展_IgA肾病中补体系统的活化及临床意义[J] .中华医学杂志,2018,298(14):1044-1047.
|
[15] |
Gharavi AG, Kiryluk K, Choi M, et al. Genome-wide association study identifies susceptibility loci for IgA nephropathy [J]. Nat Genet, 2011, 43(4): 321-327.
|
[16] |
Medjeral-Thomas N, Pickering MC. The complement factor H-related proteins [J]. Immunol Rev, 2016, 274(1): 191-201.
|
[17] |
Goicoechea de Jorge E, Caesar JJ, Malik TH, et al. Dimerization of complement factor H-related proteins modulates complement activation in vivo [J]. Proc Natl Acad Sci USA, 2013, 110(12): 4685-4690.
|
[18] |
Zhai YL, Meng SJ, Zhu L, et al. Rare variants in the complement factor H-related protein 5 gene contribute to genetic susceptibility to IgA nephropathy [J]. J Am Soc Nephrol, 2016, 27(9): 2894-2905.
|
[19] |
Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, et al. Human IgA activates the complement system via the mannan-binding lectin pathway [J]. J Immunol, 2001, 167(5): 2861-2868.
|
[20] |
Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease [J]. J Am Soc Nephrol, 2006, 17(6): 1724-1734.
|
[21] |
Chandra P. C4d in native glomerular diseases [J]. Am J Nephrol, 2019, 49(1): 81-92.
|
[22] |
Gong R, Liu Z, Li L. Mannose-binding lectin gene polymorphism associated with the patterns of glomerular immune deposition in IgA nephropathy [J]. Scand J Urol Nephrol, 2001, 35(3): 228-232.
|
[23] |
Shi B, Wang L, Mou S, et al. Identification of mannose-binding lectin as a mechanism in progressive immunoglobulin A nephropathy [J]. Int J Clin Exp Pathol, 2015, 8(2): 1889-1899.
|
[24] |
Lee HJ, Choi SY, Jeong KH, et al. Association of C1q deposition with renal outcomes in IgA nephropathy [J]. Clin Nephrol, 2013, 80(2): 98-104.
|
[25] |
丁冉冉,邢广群,王纪霞,等. IgA肾病患者补体经典途径在血液及尿液中的活化及与肾损伤的关系[J]. 临床内科杂志,2014,31(3) 186-188.
|
[26] |
Zwirner J, Burg M, Schulze M, et al. Activated complement C3: a potentially novel predictor of progressive IgA nephropathy [J]. Kidney Int, 1997, 51(4): 1257-1264.
|
[27] |
Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy [J]. PLoS One, 2012, 7(7): e40495.
|
[28] |
Guo ZY, Zhou SG, Wang YY, et al. Clinico-pathological characteristics and prognosis of IgA nephropathy patients with microalbuminuria and deposition of complement C3 [J]. Zhonghua Yi Xue Za Zhi, 2016, 96(9): 707-711.
|
[29] |
Katafuchi R, Nagae H, Masutani K, et al. Comprehensive evaluation of the significance of immunofluorescent findings on clinicopathological features in IgA nephropathy [J]. Clin Exp Nephrol, 2019, 23(2): 169-181.
|
[30] |
Kawasaki Y, Maeda R, Ohara S, et al. Serum IgA/C3 and glomerular C3 staining predict severity of IgA nephropathy [J]. Pediatr Int, 2018, 60(2): 162-167.
|
[31] |
Caliskan Y, Ozluk Y, Celik D, et al. The clinical significance of uric acid and complement activation in the progression of IgA nephropathy [J]. Kidney Blood Press Res, 2016, 41(2): 148-157.
|
[32] |
Suzuki H, Ohsawa I, Kodama F, et al. Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy [J]. J Nephrol, 2013, 26(4): 708-715.
|
[33] |
Zhu B, Zhu CF, Lin Y, et al. Clinical characteristics of IgA nephropathy associated with low complement 4 levels [J]. Ren Fail, 2014, 37(3): 424-432.
|
[1] |
Floege J, Moura IC, Daha MR. New insights into the pathogenesis of IgA nephropathy [J]. Semin Immunopathol, 2014, 36(4): 431-442.
|
[2] |
Li LS, Liu ZH. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies [J]. Kidney Int, 2004, 66(3): 920-923.
|
[3] |
Schena FP, Nistor I. Epidemiology of IgA nephropathy: a global perspective [J]. Semin Nephrol, 2018, 38(5): 435-442.
|
[34] |
Pan M, Zhang J, Li Z, et al. Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study [J]. BMC Nephrol, 2017, 18(1): 231-238.
|
[35] |
Wen L, Zhao Z, Wang Z, et al. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in IgA nephropathy [J]. Nephrology (Carlton), 2019, 24(7): 703-710.
|
[36] |
Zhang JJ, Jiang L, Liu G, et al. Levels of urinary complement factor H in patients with IgA nephropathy are closely associated with disease activity [J]. Scand J Immunol, 2009, 69(5): 457-464.
|
[37] |
Zhu L, Guo WY, Shi SF, et al. Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy [J]. Kidney Int, 2018, 94(1): 150-158.
|
[38] |
Medjeral-Thomas NR, Lomax-Browne HJ, Beckwith H, et al. Circulating complement factor H-related proteins 1 and 5 correlate with disease activity in IgA nephropathy [J]. Kidney Int, 2017, 92(4): 942-952.
|
[39] |
Pan M, Zhou Q, Zheng S, et al. Serum C3/C4 ratio is a novel predictor of renal prognosis in patients with IgA nephropathy: a retrospective study [J]. Immunol Res, 2018, 66(3): 381-391.
|
[40] |
Segarra-Medrano A, Carnicer-Caceres C, Valtierra-Carmeno N, et al. Study of the variables associated with local complement activation in IgA nephropathy [J]. Nefrologia, 2017, 37(3): 320-329.
|
[41] |
Sahin OZ, Yavas H, Tasll Fi, et al. Prognostic value of glomerular C4d staining in patients with IgA nephritis [J]. Int J Clin Exp Pathol, 2014, 7(6): 3299-3304.
|
[42] |
Guo WY, Zhu L, Meng SJ, et al. Mannose-binding lectin levels could predict prognosis in IgA nephropathy [J]. J Am Soc Nephrol, 2017, 28(11): 3175-3181.
|
[43] |
Liu LL, Jiang Y, Wang LN, et al. Urinary mannose-binding lectin is a biomarker for predicting the progression of immunoglobulin (Ig)A nephropathy [J]. Clin Exp Immunol, 2012, 169(2): 148-155.
|
[44] |
Medjeral-Thomas NR, Troldborg A, Constantinou N, et al. Progressive IgA nephropathy is associated with low circulating mannan-binding lectin-associated serine protease-3 (MASP-3) and increased glomerular factor H-related protein-5 (FHR5) deposition [J]. Kidney Int Rep, 2018, 3(2): 426-438.
|